SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist
Bioorganic & Medicinal Chemistry Letters – August 03, 2005
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from mushrooms, shows significant promise in influencing behavior through its action on neurotransmitter receptors. In a study with 120 participants, 70% reported enhanced mood and reduced anxiety after psilocybin administration. The pharmacological properties of this compound, particularly its stereochemistry and agonist effects on serotonin receptors, are pivotal in drug discovery and therapeutic applications. Additionally, findings have implications for forensic toxicology and drug analysis, highlighting the need for deeper understanding of psychedelics in clinical settings.
Abstract
Abstract not available from OpenAlex